Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis races to the FDA with its 'breakthrough' lung cancer drug
Fierce Biotech
Wednesday, January 29, 2014 - 10:23am
tags:
Novartis, non-small cell lung cancer, LDK378, FDA, breakthrough therapies
AstraZeneca joins stepped-up antibiotic R&D action with FOB Synthesis deal
Fierce Pharma
Wednesday, January 29, 2014 - 10:22am
tags:
AstraZeneca, antibiotics, R&D, FOB Synthesis, carbapenem
Data on Celsion's ThermoDox
Yahoo/Zacks.com
Wednesday, January 29, 2014 - 10:20am
tags:
ThermoDox, Celsion, liver cancer
Sinovac Biotech files clinical trial application in China for Avian Influenza
Yahoo/Fly on the Wall
Wednesday, January 29, 2014 - 10:18am
tags:
Sinovac Biotech, China, H7N9
Biogen plans for three new potential product launches this year
The Fly on the Wall
Wednesday, January 29, 2014 - 9:33am
tags:
Biogen Idec
The Bristol-Myers Squibb Co. Overreaction Highlights The Dependence On Oncology
Motley Fool
Wednesday, January 29, 2014 - 9:32am
tags:
oncology, Bristol-Myers Squibb
J&J Gets $257 Million Louisiana Risperdal Verdict Thrown Out
Bloomberg
Wednesday, January 29, 2014 - 9:31am
tags:
JNJ, Louisiana, Risperdal, antipsychotics, misbranding
Medivation prostate cancer drug impresses in pre-chemo study
Yahoo/Reuters
Wednesday, January 29, 2014 - 9:29am
tags:
Medivation, prostate cancer, Xtandi
On the Call: Pfizer new drugs head Geno Genaro on efforts to boost Eliquis sales over rivals
Yahoo/Reuters
Wednesday, January 29, 2014 - 9:29am
tags:
Eliquis, Pfizer
Amgen Fourth-Quarter Earnings Rise on Higher Drug Sales
Bloomberg
Wednesday, January 29, 2014 - 9:27am
tags:
Amgen, earnings
Teva Gains U.S. Approval for Higher-Dose Copaxone Therapy
Bloomberg
Wednesday, January 29, 2014 - 9:27am
tags:
Teva, Copaxone, MS, multiple sclerosis
Novartis weighs joint ventures, unconventional deals for smaller businesses
Yahoo/Reuters
Wednesday, January 29, 2014 - 9:26am
tags:
Novartis
Novartis Q4 net profit rises to $2.0 billion
Yahoo/AP
Wednesday, January 29, 2014 - 9:25am
tags:
Novartis, earnings
Biogen profit rises as new multiple sclerosis drug shines
Yahoo/Reuters
Wednesday, January 29, 2014 - 9:24am
tags:
Biogen Idec, earnings
Earnings Preview: Amgen looks to repeat strong Neupogen sales in Q4
The Fly on the Wall
Tuesday, January 28, 2014 - 3:57pm
tags:
Amgen, earnings
Biotechs Still Hold Promise in 2014 and Beyond
FOX Business
Tuesday, January 28, 2014 - 3:49pm
tags:
biotech
Is Biogen (BIIB) Poised to Beat Earnings Estimates?
Yahoo/Zacks.com
Tuesday, January 28, 2014 - 2:12pm
tags:
Biogen Idec, earnings
U.S. FDA panel: data support safety, efficacy of Merck allergy drug
Yahoo/Reuters
Tuesday, January 28, 2014 - 2:11pm
tags:
FDA, advisory panels, Merck, Ragwitek, ragweed pollen allergy
Forest Raises $1.8 Billion in Bond Sale to Fund Aptalis Takeover
Bloomberg/Businessweek
Tuesday, January 28, 2014 - 12:18pm
tags:
Forest, Aptalis, M&A, bonds
Intercept’s Fibrosis Success Gives Galectin High Hope
Wall St Cheat Sheet
Tuesday, January 28, 2014 - 12:17pm
tags:
Intercept Pharma, Galectin, Conatus Pharmaceuticals, OCA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.